You have activated the high contrast version of the site. For more info on this topic, please visit this page.
Our unit is specialized in the diagnosis and treatment of pharmacoresistant epilepsies. Because of a close collaboration with both universities (Geneva and Lausanne), the whole spectrum of modern diagnostic tools is available. Since beginning our work, more than 600 patients have been evaluated and most have also had operations; 40 to 45% of our patients were children and adolescents.
By definition, an epileptic disorder is present if several epileptic seizures occur spontaneously. Epilepsy is a relatively common disease, affecting 0.5 - 1% of the European population, which corresponds to 1.6-3.2 million people! Children and younger people are often affected, but the disorder may also begin at a later time, or even at a late age. There are many different causes of epilepsy, and its careful identification is essential for appropriate treatment. Fortunately, medication satisfactorily control most epileptic disorders, in such a way that there are no more seizures or that the remaining seizures do not interfere with daily life. However, in approximately 20% of all cases, epileptic seizures occur despite good drug compliance, in which case alternative therapeutic choices should be considered, such as surgical epilepsy therapy.
Despite treatment with one or more antiepileptic drugs and good compliance, disabling seizures persist in many patients. This is called pharmacoresistance. In a significant number of cases, a surgical intervention can improve the condition, i.e. removal of epileptic brain tissue with the ultimate goal of seizure-freedom. However, before any intervention, two criteria have to be fulfilled:
When should surgical therapy or in-patient evaluation of the epilepsy disorder be considered?
Generally speaking, the more precisely the focus can be localized, the higher are the chances of postoperative seizure-freedom - provided that the focus resides in resectable brain tissue. In the majority of cases, non-invasive exams are sufficient to pose the correct diagnosis.
The realization of all exams as well as the recording of several habitual seizures requires 1-2 weeks of hospitalization at the University Hospital of Geneva.
In 10-20% of all patients, the focus or adjacent vital cortex cannot be precisely localized sufficiently despite this comprehensive battery of tests. In some cases, invasive monitoring could be recommended, i.e. recording seizures using implanted electrodes (implantation by the neurosurgeon). In our laboratory, all invasive techniques are offered (subdural electrodes, depth electrodes, foramen ovale electrodes) which may also identify vital cortex.